Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TAL1 anticorps (AA 1-324)

TAL1 Reactivité: Poisson zèbre (Danio rerio) WB, ELISA Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7179878
  • Antigène Voir toutes TAL1 Anticorps
    TAL1 (T-Cell Acute Lymphocytic Leukemia 1 (TAL1))
    Épitope
    • 13
    • 7
    • 7
    • 6
    • 6
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-324
    Reactivité
    • 81
    • 37
    • 27
    • 6
    • 6
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    Poisson zèbre (Danio rerio)
    Hôte
    • 83
    • 7
    Lapin
    Clonalité
    • 84
    • 6
    Polyclonal
    Conjugué
    • 49
    • 7
    • 7
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp TAL1 est non-conjugé
    Application
    • 64
    • 43
    • 13
    • 9
    • 7
    • 7
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA
     Réactivité croisée
    Poisson zèbre (Danio rerio)
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Zebrafish T-cell acute lymphocytic leukemia protein 1 homolog protein (1-324AA)
    Isotype
    IgG
    Top Product
    Discover our top product TAL1 Anticorps primaire
  • Indications d'application
    Recommended dilution: WB:1:500-1:5000,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    TAL1 (T-Cell Acute Lymphocytic Leukemia 1 (TAL1))
    Autre désignation
    tal1 (TAL1 Produits)
    Synonymes
    anticorps SCL/tal-1, anticorps Scl, anticorps bHLHa17, anticorps tal-1, anticorps SCL, anticorps TCL5, anticorps scl, anticorps tcl5, anticorps SCL-alpha, anticorps SCL-beta, anticorps scl/tal1, anticorps zgc:85605, anticorps T cell acute lymphocytic leukemia 1, anticorps TAL bHLH transcription factor 1, erythroid differentiation factor, anticorps T-cell acute lymphocytic leukemia 1 S homeolog, anticorps T-cell acute lymphocytic leukemia 1, anticorps Tal1, anticorps TAL1, anticorps tal1.S, anticorps tal1
    Sujet

    Background: Transcription factor that plays a pivotal role in hemopoietic and endothelial development, acting synergistically with lmo2 and downstream of clo. Specifies mesodermal precursors to a hemangioblast cell fate. Hemangioblasts are bipotential precursors of blood and endothelium, and in the absence of hemopoietic induction cues such as gata1, tal1/scl-lmo2-induced hemangioblasts differentiate into endothelial cells. Isoform alpha and isoform beta are redundant for the initiation of primitive hemopoiesis but have distinct roles in the regulation of primitive erythroid differentiation and definitive hemopoietic stem cell specification, most likely due to differences in expression levels. Specification of definitive hemopoietic stem cells requires isoform beta. DNA binding is required for erythroid maturation, but not for its other hemopoietic functions. Endothelial roles include development of the dorsal aorta, the site of definitive hemopoiesis in the embryo. Required for angiogenesis but not angioblast specification. Has an additional role in endocardium formation during heart development. May play a role in central nervous system development.

    Aliases: tal1 antibody, scl antibody, tal-1 antibody, si:ch211-135j1.3 antibody, T-cell acute lymphocytic leukemia protein 1 homolog antibody, TAL-1 antibody, Stem cell protein antibody, zSCL antibody

    UniProt
    O93507
    Pathways
    Stem Cell Maintenance
Vous êtes ici: